M. Ruhwald (Copenhagen, Denmark), D. Goletti (Rome, Italy)
The specificity of a new skin test – Diaskintest (recombinant protein CFP10-ESAT6) in patients with sarcoidosis and non-tuberculous pulmonary diseases
N. Makarova, L. Slogotskaya, E. Kupavtseva, S. Borisov (Moscow, Russian Federation)
|  |
DIASKINTEST as a screening metod at the mass child health examination for tuberculosis in Russia
V. Aksenova (Moscow, Russian Federation)
| |
Differential diagnosis of outpatient pneumonia and infiltrative pulmonary tuberculosis by the Diaskintest®
B. Borodulin, E. Borodulina, O. Kozlova, L. Povalyaeva (Samara, Russian Federation)
| |
The role of two stage tuberculin skin test in screening of household contacts
R. Rifat, C. Peplow, K. Sadiqullah, H. Kunst (Birmingham, United Kingdom; , United States Of America)
| |
Variables responsible for tuberculin positivity of household contacts of sputum positive TB cases
A. Khan, T. Sahasrabudhe (Pune, India)
|  |
Tuberculin skin test size and risk of tuberculosis: A 12-year follow-up of contacts of TB cases
O. Morán-Mendoza, M. FitzGerald, K. Elwood, D. Patrick (Kingston, Vancouver, Canada)
| |
Comparative study of the usefulness of TST and three interferon-gamma release assasys (IGRAs) for the differential diagnosis of pulmonary tuberculosis
Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan)
| |
Comparison between tuberculin skin testing and QuantiFERON Gold-In Tube for detection of latent tuberculosis in rheumatoid arthritis patients in a TB endemic population
A. Socaci, G. Nini, E. Borgazi, V. Tudorache (Timisoara, Arad, Constanta, Romania)
| |
IGRA and TST predictive value in immunocompetent close contacts
T. Gomes, S. Campainha, A. Carvalho, R. Duarte (Vila Nova de Gaia, Vila Real, Oporto, Portugal)
| |
QFT-GIT vs TST in diagnosis of latent tuberculosis infection (LTBI) in Poland
K. Kruczak, M. Sanak, E. Nizankowska-Mogilnicka (Cracow, Poland)
| |
Indeterminate IGRA results in routine practice
P. Kewin, T. Inkster, B. Choo-Kang (Glasgow, United Kingdom)
| |
Detection of IFN-γ responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients
I. Latorre, S. Minguez, M. Vilavella, J. Diez, J. M. Carrascosa, C. Prat, L. Mateo, E. Domenech, V. Ausina, C. Ferrandiz, J. Dominguez (Badalona, Bellaterra, Spain)
| |
Screening of HIV positive TB contacts with an interferon-gamma release assay in a congregate setting in Singapore
S. H. Gan, S. Bhoopalan, K. W. KhinMar, T. M. Barkham, C. B. E. Chee, Y. T. Wang (Singapore, Singapore)
| |
QuantiFERON testing in British army recruits
R. Mackley, D. Spence (Northallerton, United Kingdom)
| |
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
C. Martyn-Simmons, J. Mee, R. Groves, H. Milburn (London, United Kingdom)
| |
Use of an IGRA test for prescribing latent TB infection therapy in 374 immigrants applying to night shelters in Milan, Italy
A. Repossi, M. Delmastro, M. Ferrarese, G. Ferrara, N. Murgia, L. Codecasa (Milan, Terni, Perugia, Italy)
| |
Practical use of quantiferon test in Norway‘s largest TB-clinic
S. Vahedi, C. Brunborg, A. M. B. Kran (Oslo, Norway)
| |